Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,568
Views
13
CrossRef citations to date
0
Altmetric
Coronaviruses

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Qian Wanga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Ziyang Songa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;d Shanghai Institute of Biological Products Co., Ltd., China National Biotec Group, Shanghai, People's Republic of China
,
Jinghuan Yanga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;e Beijing Institute of Biological Products Co., Ltd., China National Biotec Group, Beijing, People's Republic of China
,
Qian Hea Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Qunying Maoa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Yu Baia Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Jianyang Liua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Chaoqiang Ana Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;f Minhai Biotechnology Co., Ltd., Beijing, People’s Republic of China
,
Xujia Yana Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;g Changchun Institute of Biological Products Co., Ltd., China National Biotec Group, Changchun, People's Republic of China
,
Bopei Cuia Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;h Wuhan Institute of Biological Products Co., Ltd., China National Biotec Group, Wuhan, People's Republic of China
,
Lifang Songa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Dong Liua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;g Changchun Institute of Biological Products Co., Ltd., China National Biotec Group, Changchun, People's Republic of China
,
Miao Xua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of ChinaCorrespondence[email protected]
&
Zhenglun Lianga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of ChinaCorrespondence[email protected]
 show all
Pages 1145-1153 | Received 19 Jan 2022, Accepted 25 Mar 2022, Published online: 18 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.